Pasar al contenido principal

DINAMICA DE LOS AGREGADOS MACROMOLECULARES DE HETERORECEPTORES DE DOPAMINA-ADENOSINA EN ESQUIZOFRENIA Y TRASTORNOS NEURODEGENERATIVOS

PID2020-118511RB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2020
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD DE BARCELONA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 11
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Expression and Impact of Adenosine A3 Receptors on Calcium Homeostasis in Human Right Atrium

  • Tarifa, Carmen|||0000-0001-8954-6058
  • Jiménez-Sábado, Verónica|||0000-0001-7720-988X
  • Franco, Rafael|||0000-0003-2549-4919
  • Montiel, José|||0000-0002-3791-5218
  • Guerra Ramos, José María|||0000-0001-5397-9177
  • Ciruela, Francisco|||0000-0003-0832-3739
  • Madsen, Leif Hove|||0000-0001-5493-3998
Increased adenosine A receptor (AR) expression and activation underlies a higher incidence of spontaneous calcium release in atrial fibrillation (AF). Adenosine A receptors (AR) could counteract excessive AR activation, but their functional role in the atrium remains elusive, and we therefore aimed to address the impact of ARs on intracellular calcium homeostasis. For this purpose, we analyzed right atrial samples or myocytes from 53 patients without AF, using quantitative PCR, patch-clamp technique, immunofluorescent labeling or confocal calcium imaging. AR mRNA accounted for 9% and AR mRNA for 32%. At baseline, AR inhibition increased the transient inward current (I) frequency from 0.28 to 0.81 events/min (p < 0.05). Simultaneous stimulation of ARs and ARs increased the calcium spark frequency seven-fold (p < 0.001) and the I frequency from 0.14 to 0.64 events/min (p < 0.05). Subsequent AR inhibition caused a strong additional increase in the I frequency (to 2.04 events/min; p < 0.01) and increased phosphorylation at s2808 1.7-fold (p < 0.001). These pharmacological treatments had no significant effects on L-type calcium current density or sarcoplasmic reticulum calcium load. In conclusion, ARs are expressed and blunt spontaneous calcium release at baseline and upon AR-stimulation in human atrial myocytes, pointing to AR activation as a means to attenuate physiological and pathological elevations of spontaneous calcium release events.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Increased Density of Endogenous Adenosine A2A Receptors in Atrial Fibrillation, From Cellular and Porcine Models to Human Patients

  • Godoy-Marín, Hector|||0000-0002-1534-6309
  • Jiménez-Sábado, Verónica|||0000-0001-7720-988X
  • Tarifa, Carmen|||0000-0001-8954-6058
  • Ginel, Antonino|||0000-0002-8820-7545
  • Santos, Joana Larupa Dos|||0000-0002-0690-7741
  • Bentzen, Bo Hjorth
  • Madsen, Leif Hove|||0000-0001-5493-3998
  • Ciruela, Francisco|||0000-0003-0832-3739
Adenosine, an endogenous nucleoside, plays a critical role in maintaining homeostasis during stressful situations, such as energy deprivation or cellular damage. Therefore, extracellular adenosine is generated locally in tissues under conditions such as hypoxia, ischemia, or inflammation. In fact, plasma levels of adenosine in patients with atrial fibrillation (AF) are elevated, which also correlates with an increased density of adenosine A receptors (ARs) both in the right atrium and in peripheral blood mononuclear cells (PBMCs). The complexity of adenosine-mediated effects in health and disease requires simple and reproducible experimental models of AF. Here, we generate two AF models, namely the cardiomyocyte cell line HL-1 submitted to Anemonia toxin II (ATX-II) and a large animal model of AF, the right atrium tachypaced pig (A-TP). We evaluated the density of endogenous AR in those AF models. Treatment of HL-1 cells with ATX-II reduced cell viability, while the density of AR increased significantly, as previously observed in cardiomyocytes with AF. Next, we generated the animal model of AF based on tachypacing pigs. In particular, the density of the key calcium regulatory protein calsequestrin-2 was reduced in A-TP animals, which is consistent with the atrial remodelling shown in humans suffering from AF. Likewise, the density of AR in the atrium of the AF pig model increased significantly, as also shown in the biopsies of the right atrium of subjects with AF. Overall, our findings revealed that these two experimental models of AF mimicked the alterations in AR density observed in patients with AF, making them attractive models for studying the adenosinergic system in AF.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Photoswitchable Diazocine Derivative for Adenosine A3 Receptor Activation in Psoriasis

  • López Cano, Marc|||0000-0001-8885-3726
  • Scortichini, Mirko
  • Tosh, Dilip K.
  • Salmaso, Veronica
  • Ko, Tongil|||0000-0002-3070-9243
  • Salort, Glòria
  • Filgaira, Ingrid|||0000-0002-9886-3925
  • Soler, Concepció|||0000-0001-6502-5012
  • Trauner, Dirk|||0000-0002-6782-6056
  • Hernando, Jordi|||0000-0002-1126-4138
  • Jacobson, Kenneth A.|||0000-0001-8104-1493
  • Ciruela, Francisco|||0000-0003-0832-3739
Incorporating photoisomerizable moieties within drugs offers the possibility of rapid and reversible light-dependent switching between active and inactive configurations. Here, we developed a photoswitchable adenosine A3 receptor (A3R) agonist that confers optical control on this G protein-coupled receptor through noninvasive topical skin irradiation in an animal model of psoriasis. This was achieved by covalently bonding an adenosine-5'-methyluronamide moiety to a diazocine photochrome, whose singular photoswitching properties facilitated repeated interconversion between a thermally stable, biologically inactive Z agonist form and a photoinduced, pharmacologically active E configuration. As a result, our photoswitchable agonist allowed the precise modulation of A3R function both in vitro and in vivo, which led to a clear light-controlled pharmacotherapeutic effect on mouse skin lesions. This breakthrough not only demonstrates the potential of diazocine photoswitches for in vivo photopharmacology but also paves the way for the development of new strategies for skin-related diseases that require localized and temporally controlled drug action.
RIUMA. Repositorio Institucional de la Universidad de Málaga
Publicación Artículo científico (JournalArticle)

The mGlu5 Receptor Protomer-Mediated Dopamine D2 Receptor Trans-Inhibition Is Dependent on the Adenosine A2A Receptor Protomer: Implications for Parkinson’s Disease

  • Romero-Fernandez, Wilber
  • Taura, Jaume J.
  • Crans, René A. J.
  • Lopez-Cano, Marc
  • Fores-Pons, Ramon
  • Narváez, Manuel
  • Carlsson, Jens
  • Ciruela, Francisco
  • Fuxe, Kjell
  • Borroto-Escuela, Dasiel O.
The adenosine A2A receptor (A2AR), dopamine D2 receptor (D2R) and metabotropic glutamate receptor type 5 (mGluR5) form A2AR-D2R-mGluR5 heteroreceptor complexes in living cells and in rat striatal neurons. In the current study, we present experimental data supporting the view that the A2AR protomer plays a major role in the inhibitory modulation of the density and the allosteric receptor-receptor interaction within the D2R-mGluR5 heteromeric component of the A2AR-D2R-mGluR5 complex in vitro and in vivo. The A2AR and mGluR5 protomers interact and modulate D2R protomer recognition and signalling upon forming a trimeric complex from these receptors. Expression of A2AR in HEK293T cells co-expressing D2R and mGluR5 resulted in a significant and marked increase in the formation of the D2R-mGluR5 heteromeric component in both bioluminescence resonance energy transfer and proximity ligation assays. A highly significant increase of the the high-affinity component of D2R (D2RKi High) values was found upon cotreatment with the mGluR5 and A2AR agonists in the cells expressing A2AR, D2R and mGluR5 with a significant effect observed also with the mGluR5 agonist alone compared to cells expressing only D2R and mGluR5. In cells co-expressing A2AR, D2R and mGluR5, stimulation of the cells with an mGluR5 agonist like or D2R antagonist fully counteracted the D2R agonist-induced inhibition of the cAMP levels which was not true in cells only expressing mGluR5 and D2R. In agreement, the mGluR5-negative allosteric modulator raseglurant significantly reduced the haloperidol-induced catalepsy in mice, and in A2AR knockout mice, the haloperidol action had almost disappeared, supporting a functional role for mGluR5 and A2AR in enhancing D2R blockade resulting in catalepsy. The results represent a relevant example of integrative activity within higher-order heteroreceptor complexes., Karolinska Institutet (Open access funding), Swedish Research Council (Vetenskapsrådet), ParkinsonFonden, Hjärnfonden, Karolinska Institutet Forskningsstiftelser, Plan Andaluz de Investigación, Desarrollo e Innovación (PAIDI) – EMERGIA (Junta de Andalucía), Olle Engkvists Stiftelse, MCIN/AEI (Ministerio de Ciencia e Innovación / Agencia Estatal de Investigación, España), FEDER (Fondo Europeo de Desarrollo Regional), CERCA Programme (Generalitat de Catalunya) / IDIBELL (institutional support)
Minerva. Repositorio Institucional de la Universidad de Santiago de Compostela
Publicación Artículo científico (JournalArticle)

Exploring Biginelli-based scaffolds as A2B adenosine receptor antagonists: Unveiling novel structure-activity relationship trends, lead compounds, and potent colorectal anticancer agents

  • Prieto Díaz, Rubén
  • Fojo Carballo, Hugo
  • Majellaro, María
  • Tandarić, Tana
  • Azuaje Guerrero, Jhonny Alberto
  • Brea Floriani, José Manuel
  • Loza García, María Isabel
  • Barbazán García, Jorge
  • Salort, Glòria
  • Chotalia, Meera
  • Rodríguez Pampín, Iván
  • Mallo Abreu, Ana
  • Paleo Pillado, María Rita
  • García Mera, Xerardo
  • Ciruela, Francisco
  • Gutiérrez de Terán, Hugo
  • Sotelo Pérez, Eddy
Antagonists of the A2B adenosine receptor have recently emerged as targeted anticancer agents and immune checkpoint inhibitors within the realm of cancer immunotherapy. This study presents a comprehensive evaluation of novel Biginelli-assembled pyrimidine chemotypes, including mono-, bi-, and tricyclic derivatives, as A2BAR antagonists. We conducted a comprehensive examination of the adenosinergic profile (both binding and functional) of a large compound library consisting of 168 compounds. This approach unveiled original lead compounds and enabled the identification of novel structure-activity relationship (SAR) trends, which were supported by extensive computational studies, including quantum mechanical calculations and free energy perturbation (FEP) analysis. In total, 25 molecules showed attractive affinity (Ki < 100 nM) and outstanding selectivity for A2BAR. From these, five molecules corresponding to the new benzothiazole scaffold were below the Ki < 10 nM threshold, in addition to a novel dual A2A/A2B antagonist. The most potent compounds, and the dual antagonist, showed enantiospecific recognition in the A2BAR. Two A2BAR selective antagonists and the dual A2AAR/A2BAR antagonist reported in this study were assessed for their impact on colorectal cancer cell lines. The results revealed a significant and dose-dependent reduction in cell proliferation. Notably, the A2BAR antagonists exhibited remarkable specificity, as they did not impede the proliferation of non-tumoral cell lines. These findings support the efficacy and potential that A2BAR antagonists as valuable candidates for cancer therapy, but also that they can effectively complement strategies involving A2AAR antagonism in the context of immune checkpoint inhibition
Minerva. Repositorio Institucional de la Universidad de Santiago de Compostela
Publicación Artículo científico (JournalArticle)

Conformational Restriction of Designer Drugs Reveals Subtype-Selective and Biased CB2 Agonists with Neuroprotective Effects

  • Prieto Díaz, Rubén
  • Gioé Gallo, Claudia
  • Ortigueira Noya, Sandra
  • García Mera, Xerardo
  • Azuaje Guerrero, Jhonny Alberto
  • Andújar Arias, Antonio
  • García Rey, Aitor
  • Graciano, Giovanni
  • Val García, Cristina
  • Martínez Rodríguez, Antón Leandro
  • Reza, David
  • Selas Lanseros, Asier
  • Francavilla, Fabio
  • Paleo Pillado, María Rita
  • Loza García, María Isabel
  • Brea Floriani, José Manuel
  • Sotelo Pérez, Eddy
This study presents the design, synthesis, and characterization of a novel series of structurally simple, selective, and functionally biased CB2 receptor (CB2R) agonists with potent anti-inflammatory and neuroprotective properties. These compounds were developed using a conformational restriction strategy to abolish CB1R binding, thereby enhancing CB2R selectivity. Pharmacological profiling identified ligands with distinct bias toward β-arrestin, MAPK, and G-protein signaling pathways. The series exhibits favorable drug-like properties, including high BBB permeability, low P-glycoprotein interaction, and microsomal stability. Representative compounds demonstrated neuroprotective activity in mouse primary neuronal assays and significantly reduced ROS and caspase levels in vitro, indicating mitigation of oxidative stress and apoptosis. In a neuron-like SH-SY5Y model expressing pathogenic mutations, they preserved neurite complexity in a CB2R-dependent manner. Collectively, these findings highlight the advantages of conformational restriction in transforming abused promiscuous, neurotoxic ligands into highly selective and efficacious agents for the treatment of neurodegenerative disorders, without CB1R-mediated psychoactive effects.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Increased Density of Endogenous Adenosine A2A Receptors in Atrial Fibrillation: From Cellular and Porcine Models to Human Patients

  • Godoy-Marín, Héctor
  • Jiménez-Sábado, Verónica
  • Tarifa, Carmen
  • Ginel, Antonino
  • Santos, Joana Larupa Dos
  • Bentzen, Bo Hjorth
  • Hove-Madsen, Leif
  • Ciruela, Francisco
Adenosine, an endogenous nucleoside, plays a critical role in maintaining homeostasis during stressful situations, such as energy deprivation or cellular damage. Therefore, extracellular adenosine is generated locally in tissues under conditions such as hypoxia, ischemia, or inflammation. In fact, plasma levels of adenosine in patients with atrial fibrillation (AF) are elevated, which also correlates with an increased density of adenosine A2A receptors (A2ARs) both in the right atrium and in peripheral blood mononuclear cells (PBMCs). The complexity of adenosine-mediated effects in health and disease requires simple and reproducible experimental models of AF. Here, we generate two AF models, namely the cardiomyocyte cell line HL-1 submitted to Anemonia toxin II (ATX-II) and a large animal model of AF, the right atrium tachypaced pig (A-TP). We evaluated the density of endogenous A2AR in those AF models. Treatment of HL-1 cells with ATX-II reduced cell viability, while the density of A2AR increased significantly, as previously observed in cardiomyocytes with AF. Next, we generated the animal model of AF based on tachypacing pigs. In particular, the density of the key calcium regulatory protein calsequestrin-2 was reduced in A-TP animals, which is consistent with the atrial remodelling shown in humans suffering from AF. Likewise, the density of A2AR in the atrium of the AF pig model increased significantly, as also shown in the biopsies of the right atrium of subjects with AF. Overall, our findings revealed that these two experimental models of AF mimicked the alterations in A2AR density observed in patients with AF, making them attractive models for studying the adenosinergic system in AF., This work was supported by the FEDER-EU/Ministerio de Ciencia, Innovación y Universidades-Agencia Estatal de Investigación (PID2020-118511RB-I00 and PID2020-116927RB-C21), Generalitat de Catalunya (2017SGR1604 and 2017SGR1769), and Fundació la Marató de TV3 (Grant 20152030/31)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Expression and Impact of Adenosine A3 Receptors on Calcium Homeostasis in Human Right Atrium

  • Tarifa, Carmen
  • Jiménez-Sábado, Verónica
  • Franco, Rafael
  • Montiel, José
  • Guerra Ramos, José María
  • Ciruela, Francisco
  • Hove-Madsen, Leif
Increased adenosine A2A receptor (A2AR) expression and activation underlies a higher incidence of spontaneous calcium release in atrial fibrillation (AF). Adenosine A3 receptors (A3R) could counteract excessive A2AR activation, but their functional role in the atrium remains elusive, and we therefore aimed to address the impact of A3Rs on intracellular calcium homeostasis. For this purpose, we analyzed right atrial samples or myocytes from 53 patients without AF, using quantitative PCR, patch-clamp technique, immunofluorescent labeling or confocal calcium imaging. A3R mRNA accounted for 9% and A2AR mRNA for 32%. At baseline, A3R inhibition increased the transient inward current (ITI) frequency from 0.28 to 0.81 events/min (p < 0.05). Simultaneous stimulation of A2ARs and A3Rs increased the calcium spark frequency seven-fold (p < 0.001) and the ITI frequency from 0.14 to 0.64 events/min (p < 0.05). Subsequent A3R inhibition caused a strong additional increase in the ITI frequency (to 2.04 events/min; p < 0.01) and increased phosphorylation at s2808 1.7-fold (p < 0.001). These pharmacological treatments had no significant effects on L-type calcium current density or sarcoplasmic reticulum calcium load. In conclusion, A3Rs are expressed and blunt spontaneous calcium release at baseline and upon A2AR-stimulation in human atrial myocytes, pointing to A3R activation as a means to attenuate physiological and pathological elevations of spontaneous calcium release events., This research was funded by FEDER-EU/Ministerio de Ciencia e Innovación (PID2020-116927RB-C21 to LH-M and PID2020-118511RB-I00 to FC) Generalitat de Catalunya (2017SGR1769 to LH-M and 2017SGR1604 to FC), Fundació la Marató de TV3 (Grant 20152030/31 to LH-M/FC)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Alteration in the Synaptic and Extrasynaptic Organization of AMPA Receptors in the Hippocampus of P301S Tau Transgenic Mice

  • Alfaro-Ruiz, Rocio
  • Aguado, Carolina
  • Martín-Belmonte, Alejandro
  • Moreno-Martínez, Ana Esther
  • Merchán-Rubira, Jesús
  • Hernández, Félix
  • Ávila, Jesús
  • Fukazawa, Yugo
  • Luján, Rafael
Tau pathology is a hallmark of Alzheimer’s disease (AD) and other tauopathies, but how pathological tau accumulation alters the glutamate receptor dynamics driving synaptic dysfunction is unclear. Here, we determined the impact of tau pathology on AMPAR expression, density, and subcellular distribution in the hippocampus of P301S mice using immunoblot, histoblot, and quantitative SDS-digested freeze-fracture replica labeling (SDS-FRL). Histoblot and immunoblot showed differential regulation of GluA1 and GluA2 in the hippocampus of P301S mice. The GluA2 subunit was downregulated in the hippocampus at 3 months while both GluA1 and GluA2 subunits were downregulated at 10 months. However, the total amount of GluA1-4 was similar in P301S mice and in age-matched wild-type mice. Using quantitative SDS-FRL, we unraveled the molecular organization of GluA1-4 in various synaptic connections at a high spatial resolution on pyramidal cell spines and interneuron dendrites in the CA1 field of the hippocampus in 10-month-old P301S mice. The labeling density for GluA1-4 in the excitatory synapses established on spines was significantly reduced in P301S mice, compared to age-matched wild-type mice, in the strata radiatum and lacunosum-moleculare but unaltered in the stratum oriens. The density of synaptic GluA1-4 established on interneuron dendrites was significantly reduced in P301S mice in the three strata. The labeling density for GluA1-4 at extrasynaptic sites was significantly reduced in several postsynaptic compartments of CA1 pyramidal cells and interneurons in the three dendritic layers in P301S mice. Our data demonstrate that the progressive accumulation of phospho-tau is associated with alteration of AMPARs on the surface of different neuron types, including synaptic and extrasynaptic membranes, leading to a decline in the trafficking and synaptic transmission, thereby likely contributing to the pathological events taking place in AD., This work was supported by grants from the Spanish Ministerio de Economía y Competitividad (RTI2018-095812-B-I00 and PID2020-118511RB-I00) and Junta de Comunidades de Castilla-La Mancha (SBPLY/17/180501/000229 and SBPLY/21/180501/000064) to RL, Life Science Innovation Center at University of Fukui and JSPS KAKENHI Grant Numbers 16H04662, 19H03323 and 20H05058) to YF, and Margarita Salas fellowship from Ministerio de Universidades and Universidad de Castilla-La Mancha to AMB.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Progress on the development of Class A GPCR-biased ligands

  • Morales, Paula
  • Scharf, Magdalena M.
  • Bermudez, Marcel
  • Egyed, Attila
  • Franco, Rafael
  • Hansen, Olivia K.
  • Jagerovic, Nadine
  • Jakubík, Jan
  • Keserű, György M.
  • Kiss, Dóra Judit
  • Kozielewicz, Pawel
  • Larsen, Olav
  • Majellaro, Maria
  • Mallo-Abreu, Ana
  • Navarro, Gemma
  • Prieto-Díaz, Rubén
  • Rosenkilde, Mette M.
  • Sotelo, Eddy
  • Stark, Holger
  • Werner, Tobias
  • Wingler, Laura M.
Class A G protein-coupled receptors (GPCRs) continue to garner interest for their essential roles in cell signalling and their importance as drug targets. Although numer- ous drugs in the clinic target these receptors, over 60% GPCRs remain unexploited. Moreover, the adverse effects triggered by the available unbiased GPCR modulators, limit their use and therapeutic value. In this context, the elucidation of biased signal- ling has opened up new pharmacological avenues holding promise for safer therapeu- tics. Functionally selective ligands favour receptor conformations facilitating the recruitment of specific effectors and the modulation of the associated pathways. This review surveys the current drug discovery landscape of GPCR-biased modulators with a focus on recent advances. Understanding the biological effects of this prefer- ential coupling is at different stages depending on the Class A GPCR family. There- fore, with a focus on individual GPCR families, we present a compilation of the functionally selective modulators reported over the past few years. In doing so, we dissect their therapeutic relevance, molecular determinants and potential clinical applications., National Office of Research, Development and Innovation, Grant/Award Number: RRF- 2.3.1-21-2022-00015; Ministerio de Ciencia e Innovación, Grant/Award Numbers: FJC2021-047571-I, PID2020-118511RB-I00, PID2021-124010OB-100, PID2021-126600OB-I00, PID2021-127833OB-I00, PID2022- 139197OA-I00; Cancerfonden, Grant/Award Number: 20 0264; National Institutes of Health, Grant/Award Number: R01 DA0455698; German Research Foundation, Grant/Award Numbers: 470002134, GRK 2158; Swedish Society for Medical Research, Grant/Award Number: PG-22-0379-H-01; Hungarian Academy of Sciences, Grant/Award Number: NAP 3.0; Consellería de Cultura, Educación e Ordenación Universitaria of the Galician Government, Grant/Award Number: ED431B 2020/43; Centro Singular de Investigación de Galicia Accreditation 2019– 2022, Grant/Award Number: ED431G 2019/03; MCIN/ AEI/10.13039/501100011033/FEDER, UE, Grant/Award Number: FJC2021-047571-I; Karolinska Institutet, the Swedish Cancer Society, Grant/Award Number: 20 0264; Swedish Research Council, Grant/Award Number: 2022-01398; Czech Academy of Sciences, Grant/Award Number: 67985823; Grant Agency of Czech Republic, Grant/Award Number: 23-04670S; Juan de la Cierva Incorporación Programme, Grant/Award Number: IJC 2019-042182-I; The Pew Charitable Trusts; COST (European Cooperation in Science and Technology), Grant/Award Number: CA18133, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

A combination of Δ9-tetrahydrocannabinol and cannabidiol modulates glutamate dynamics in the hippocampus of an animal model of Alzheimer's disease

  • Sánchez-Fernández, Nuria
  • Gómez-Acero, Laura
  • Castañé, Anna
  • Adell, Albert
  • Campa, Leticia
  • Bonaventura, Jordi
  • Brito, Verónica
  • Ginés, Silvia
  • Queiróz, Francisco
  • Silva, Henrique
  • Lopes, João Pedro
  • Lopes, Cátia R
  • Radošević, Marija
  • Gasull, Xavier
  • Cunha, Rodrigo A.
  • Köfalvi, Attila
  • Ferreira, Samira G.
  • Ciruela, Francisco
  • Aso, Ester
A combination of Δ9-tetrahydrocannabinol (Δ9-THC) and cannabidiol (CBD) at non-psychoactive doses was previously demonstrated to reduce cognitive decline in APP/PS1 mice, an animal model of Alzheimer's disease (AD). However, the neurobiological substrates underlying these therapeutic properties of Δ9-THC and CBD are not fully understood. Considering that dysregulation of glutamatergic activity contributes to cognitive impairment in AD, the present study evaluates the hypothesis that the combination of these two natural cannabinoids might reverse the alterations in glutamate dynamics within the hippocampus of this animal model of AD. Interestingly, our findings reveal that chronic treatment with Δ9-THC and CBD, but not with any of them alone, reduces extracellular glutamate levels and the basal excitability of the hippocampus in APP/PS1 mice. These effects are not related to significant changes in the function and structure of glutamate synapses, as no relevant changes in synaptic plasticity, glutamate signaling or in the levels of key components of these synapses were observed in cannabinoid-treated mice. Our data instead indicate that these cannabinoid effects are associated with the control of glutamate uptake and/or to the regulation of the hippocampal network. Taken together, these results support the potential therapeutic properties of combining these natural cannabinoids against the excitotoxicity that occurs in AD brains., This study was supported by Ministerio de Ciencia, Innovación y Universidades–Agencia Estatal de Investigación-FEDER funds/European Regional Development Fund – “a way to build Europe” grants RTI2018-097773-A-I00 and PID2022-141123OB-I00 to EA, PID2020-118511RB-I00 to FC, PID2020-119305RB-I00 to XG and PID2020-117989RA-I00 to JB, by Departament de Recerca i Universitats de la Generalitat de Catalunya (2021 SGR 00698) to FC and by CYTED-Programa Iberoamericano de Ciencia y Tecnología para el Desarrollo (P219RT0008) to EA. Founded by MCIN/AEI/10.13039/501100011033 “ESF Investing in your future” grant PRE2019-088153 to NSF and grant FPU19/03142 to LGA., Peer reviewed